SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001140361-21-018713
Filing Date
2021-05-25
Accepted
2021-05-25 17:03:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A brhc10025106_sc13da.htm SC 13D/A 61801
  Complete submission text file 0001140361-21-018713.txt   63017
Mailing Address 745 FIFTH AVENUE SUITE 1602 NEW YORK NY 10151
Business Address 745 FIFTH AVENUE SUITE 1602 NEW YORK NY 10151 519.322.8800
Tilray, Inc. (Subject) CIK: 0001731348 (see all company filings)

IRS No.: 824310622 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91265 | Film No.: 21961550
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address 1920 EASTLAKE AVENUE E. SEATTLE WA 98105
Business Address
Kennedy Brendan (Filed by) CIK: 0001746070 (see all company filings)

Type: SC 13D/A